Is there a causal link between hepatitis B vaccination and multiple sclerosis?
- PMID: 10706960
- DOI: 10.1016/s0264-410x(99)00533-2
Is there a causal link between hepatitis B vaccination and multiple sclerosis?
Abstract
After the publication of case reports of hepatitis B vaccinees with onset or relapse of multiple sclerosis (MS), followed by a media-driven scare campaign in France, the perception that hepatitis B vaccine causes MS has developed. This has led to a fall in the acceptance of hepatitis B vaccination particularly in French-speaking communities which was accelerated by court decisions in favour of vaccination "victims" and the suspension of routine vaccination of pre-adolescents in French schools as a "precautionary measure". This situation has arisen in spite of the absence of scientific data to support a causal link between vaccination and multiple sclerosis. In this article, initially written to inform and reassure employees of one of the vaccine manufacturers, the epidemiological importance of hepatitis B and current knowledge on the aetiology of MS are described. All available data that may throw light on the hypothesis that hepatitis B vaccination is causally linked to MS was reviewed. The conclusion reached on the basis of available data is that the most plausible explanation for the observed temporal association between vaccination and MS is that it is a coincidental association. It is now important to rebuild public confidence in hepatitis B vaccine as well as in vaccination in general.
Similar articles
-
[Hepatitis B vaccination. Advocating for a protection principle].Bull Acad Natl Med. 2002;186(2):361-6; discussion 366-8. Bull Acad Natl Med. 2002. PMID: 12145843 French.
-
Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.Vaccine. 2019 Apr 3;37(15):2142-2148. doi: 10.1016/j.vaccine.2019.02.046. Epub 2019 Mar 6. Vaccine. 2019. PMID: 30851966
-
Hepatitis B vaccine and risk of multiple sclerosis.Expert Rev Vaccines. 2002 Dec;1(4):461-6. doi: 10.1586/14760584.1.4.461. Expert Rev Vaccines. 2002. PMID: 12901584 Review.
-
Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B.Neurol Sci. 2000;21(4 Suppl 2):S853-6. doi: 10.1007/s100720070025. Neurol Sci. 2000. PMID: 11205362 Review.
-
Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.Ital J Gastroenterol Hepatol. 1999 Jun-Jul;31(5):388-91. Ital J Gastroenterol Hepatol. 1999. PMID: 10470598
Cited by
-
Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.Cell Mol Immunol. 2018 Jun;15(6):586-594. doi: 10.1038/cmi.2017.151. Epub 2018 Mar 5. Cell Mol Immunol. 2018. PMID: 29503439 Free PMC article. Review.
-
Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics.Vaccine. 2009 May 26;27(25-26):3240-4. doi: 10.1016/j.vaccine.2009.01.069. Epub 2009 Feb 5. Vaccine. 2009. PMID: 19200833 Free PMC article. Review.
-
[Vaccination and multiple sclerosis].Nervenarzt. 2010 Feb;81(2):181-93. doi: 10.1007/s00115-009-2865-3. Nervenarzt. 2010. PMID: 19838662 Review. German.
-
Probable epitopes: Relationships between myelin basic protein antigenic determinants and viral and bacterial proteins.Neuroinformatics. 2004;2(1):59-70. doi: 10.1385/NI:2:1:059. Neuroinformatics. 2004. PMID: 15067168
-
Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.Ther Adv Neurol Disord. 2014 Mar;7(2):137-49. doi: 10.1177/1756285613501575. Ther Adv Neurol Disord. 2014. PMID: 24587828 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical